Rapid Micro Biosystems Azioni (NASDAQ: RPID)

Ultime notizie per Rapid Micro Biosystems (NASDAQ:RPID) Azioni

Rapid Micro Biosystems

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems Inc

Rapid Micro Biosystems reports mixed Q2 results; reaffirms FY24 outlook

Rapid Micro Biosystems, Inc. (RPID) Q2 2024 Earnings Call Transcript

Rapid Micro Biosystems (RPID) has received a new Buy rating, initiated by TD Cowen analyst, Steven Mah. Steven Mah has given his Buy rating due to ...

Buy Rating Affirmed for Rapid Micro Biosystems Amid Strong Revenue Growth and Strategic Cost-Saving Initiatives

Morgan Stanley analyst Tejas Savant maintained a Hold rating on Rapid Micro Biosystems (RPID – Research Report) today and set a price target of $1....

Morgan Stanley Remains a Hold on Rapid Micro Biosystems (RPID)

Rapid Micro Biosystems GAAP EPS of -$0.26 in-line, revenue of $7.6M beats by $1.05M

Reports Q3 revenue $7.6M vs. $6.1M last year. "We are pleased to report record quarterly revenue, accelerating system placements and a positive inf...

Rapid Micro Biosystems reports Q3 EPS (26c) vs. (31c) last year

The Company is reaffirming its full year 2024 total revenue guidance of at least $27.0 million, representing growth of at least 20% compared to ful...

Rapid Micro Biosystems reaffirms FY24 revenue view of at least $27M

TD Cowen analyst Brendan Smith maintained a Buy rating on Rapid Micro Biosystems (RPID – Research Report) today. The company's shares opened today ...

TD Cowen Reaffirms Their Buy Rating on Rapid Micro Biosystems (RPID)

Rapid Micro Biosystems, Inc. (RPID) Q3 2024 Earnings Call Transcript

Rapid Micro Biosystems, Inc. Class A ( ($RPID) ) has released its Q3 earnings. Here is a breakdown of the information Rapid Micro Biosystems, Inc. ...

Rapid Micro Biosystems Reports Strong Q3 2024 Growth

RPID

News

Press Releases

Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum

Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024

Biotech

General

Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024

Earnings

Rapid Micro Biosystems Reports First Quarter 2024 Financial Results

Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024

Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results

Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024

Health Care

Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results

Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference

Akoya Biosciences

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Bionano Genomics

Conduit Pharmaceuticals Inc. - Common Stock

Conduit Pharmaceuticals

Codexis

Champions Oncology

Harvard Bioscience

Lifecore Biomedical

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

Singular Genomics Systems, Inc. - Common Stock

Singular Genomics Sys

Personalis

Quantum-Si Incorporated - Class A Common Stock

Comments

Rapid Micro Biosystems

Notizie

Ultime notizie per Rapid Micro Biosystems (NASDAQ:RPID) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO